Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2024 ∙ Ryoo, S. Choi, M. Choi, N. K. Shin, H. S. Woo, J. H. Park, B. J. Oh, S.

Psychiatric adverse events associated with the COVID-19 vaccines approved in the Republic of Korea: a systematic review

  • Western Pacific
  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Rizzo, M. Gattino, S. Trombetta, T. Calandri, E. De Piccoli, N.

Psychosocial dimensions of vaccine hesitancy: A systematic review

  • All age groups
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ de Fougerolles, T. R. Baissas, T. Perquier, G. Vitoux, O. Crepey, P. Bartelt-Hofer, J. Bricout, H. Petitjean, A.

Public health and economic benefits of seasonal influenza vaccination in risk groups in France, Italy, Spain and the UK: state of play and perspectives

  • Europe
  • France
  • Italy
  • Spain
  • United Kingdom
  • All age groups
  • Influenza
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Olszewska, B. Zarycza Nowicki, R. J. Sokołowska-Wojdyło, M.

Rare COVID-19 vaccine side effects got lost in the shuffle. Primary cutaneous lymphomas following COVID-19 vaccination: a systematic review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Guo, J. Chen, X. Guo, Y. Liu, M. Li, P. Tao, Y. Liu, Z. Yang, Z. Zhan, S. Sun, F.

Real-world effectiveness of seasonal influenza vaccination and age as effect modifier: A systematic review, meta-analysis and meta-regression of test-negative design studies

  • All age groups
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Yang, X. Shi, N. Liu, C. Zhang, J. Miao, R. Jin, H.

Relationship between vaccine hesitancy and vaccination behaviors: Systematic review and meta-analysis of observational studies

  • All age groups
  • Parents/caregivers
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Nealon, J. Mefsin, Y. M. McMenamin, M. E. Ainslie, K. E. C. Cowling, B. J.

Reported effectiveness of COVID-19 monovalent booster vaccines and hybrid immunity against mild and severe Omicron disease in adults: A systematic review and meta-regression analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Mapindra, M. P. Mahindra, M. P. McNamara, P. Semple, M. G. Clark, H. Madsen, J.

Respiratory Syncytial Virus Maternal Vaccination in Infants below 6 Months of Age: Meta-Analysis of Safety, Immunogenicity, and Efficacy

  • Pregnant women
  • Newborn
  • RSV (Respiratory syncytial virus)
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Phijffer, Ewem de Bruin, O. Ahmadizar, F. Bont, L. J. Van der Maas, N. A. T. Sturkenboom, Mcjm Wildenbeest, J. G. Bloemenkamp, K. W. M.

Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes

  • Pregnant women
  • RSV (Respiratory syncytial virus)
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
High
2024 ∙ Srichawla, B. S. Fang, T. Kipkorir, V. Garcia-Dominguez, M. A.

Reversible cerebral vasoconstriction syndrome and posterior reversible encephalopathy syndrome following vaccination: analysis of the VAERS database and systematic review

  • Adults
  • Older adults
  • COVID-19
  • Measles
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...